HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The molecular genetics of the congenital long QT syndromes.

Abstract
During the past half decade, significant insight into the clinical electrocardiographic, and genetic features of the congenital long QT syndromes has emerged. Based on this foundation, recent linkage analysis studies have demonstrated the genetic heterogeneity of the Romano-Ward long QT syndrome and led to the discovery of two of the four (or more) responsible genes. Further functional characterization of these two genes, the HERG potassium channel and the SCN5A voltage-gated cardiac sodium channel, as well as the identification and characterization of the other long QT syndrome genes, may allow improved diagnosis and therapy for these disorders. Furthermore, the increased understanding of myocardial repolarization that is gained from characterization of these genes may lead to improved treatment for other ventricular arrhythmias, including those related to potassium-channel blockade, central nervous system insult, and, possibly, myocardial infarction.
AuthorsM W Russell, M Dick 2nd
JournalCurrent opinion in cardiology (Curr Opin Cardiol) Vol. 11 Issue 1 Pg. 45-51 (Jan 1996) ISSN: 0268-4705 [Print] United States
PMID8664531 (Publication Type: Journal Article, Review)
Chemical References
  • Cation Transport Proteins
  • DNA-Binding Proteins
  • ERG protein, human
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human
  • KCNH6 protein, human
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Trans-Activators
  • Transcriptional Regulator ERG
Topics
  • Animals
  • Cation Transport Proteins
  • Chromosomes, Human, Pair 4 (genetics)
  • DNA-Binding Proteins
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Genetic Linkage
  • Humans
  • Long QT Syndrome (congenital, genetics)
  • Myocardium (cytology)
  • Potassium Channels (genetics)
  • Potassium Channels, Voltage-Gated
  • Trans-Activators
  • Transcriptional Regulator ERG

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: